Finance

Lists
476060:KOSDAQ
Onconic Therapeutics Inc
₩13,860.00
-0.29%
(-40.00) 1D
Oct 19, 3:30:28 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 476060...
Open
₩13,300
High
₩13,900
Low
₩13,300
Mkt. cap
629.35B
Avg. vol.
358.74K
Volume
84.48K
P/E ratio
25.96
52-wk high
₩28,900
52-wk low
₩8,790
EPS
₩534
Shares outstanding
45.41M
No. of employees
38
Open
₩13,300
High
₩13,900
Low
₩13,300
Mkt. cap
629.35B
Avg. vol.
358.74K
Volume
84.48K
P/E ratio
25.96
52-wk high
₩28,900
52-wk low
₩8,790
EPS
₩534
Shares outstanding
45.41M
No. of employees
38
News stories
From web sources and news partners
About Onconic Therapeutics Inc
CEO-
Employees38
Founded2020
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.21B
15.58B
22.98B
24.40B
Cost of goods sold
-
420.00K
2.80M
9.80M
Cost of revenue
-
420.00K
2.80M
9.80M
Research and development expenses
-
3.63B
4.25B
6.29B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.90B
10.15B
13.94B
15.08B
Operating expense
10.90B
13.97B
18.39B
21.60B
Total operating expenses
10.90B
13.97B
18.40B
21.61B
Operating income
8.32B
1.61B
4.59B
2.79B
Other non operating income
1.09B
1.69M
3.14K
16.72K
EBT including unusual items
9.40B
2.60B
6.44B
3.77B
EBT excluding unusual items
9.40B
2.59B
6.44B
3.77B
Income tax expense
-
-2.06B
16.83M
-
Effective tax rate
-
-79.24%
0.26%
-
Other operating expenses
-
49.89M
65.22M
79.08M
Net income
9.40B
4.66B
6.42B
3.77B
Net profit margin
48.94%
29.91%
27.94%
15.44%
Earnings per share
-
-
-
-
Interest and investment income
-
376.24M
388.06M
406.92M
Interest expense
-2.62M
-2.02M
-1.54M
-2.82M
Net interest expenses
-2.62M
374.22M
386.53M
404.10M
Depreciation and amortization charges
-
137.14M
141.57M
154.10M
EBITDA
8.43B
1.74B
4.72B
2.94B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps